Document Detail

Multiple marker screening for Down syndrome in twin pregnancies.
MedLine Citation:
PMID:  8821849     Owner:  NLM     Status:  MEDLINE    
This study documents the screening performance, in practice, of a published protocol for interpreting second-trimester Down syndrome risk in twin pregnancies, using maternal serum biochemical markers. Within a cohort of 35,150 pregnancies, 410 twin pregnancies were identified. The rate of twinning was positively associated with maternal age. Of the 274 twin pregnancies known prior to screening, 15 (5.5 per cent) were classified as being screen-positive for Down syndrome. When maternal age and dating method were taken into account, the screen-positive rates in twin and singleton pregnancies did not differ significantly. Nine of the 14 screen-positive women with viable twin pregnancies chose amniocentesis [64 per cent, 95 per cent confidence interval (CI) 35-87]. No cases of Down syndrome were identified. Based on modelling, an estimated 73 per cent of monozygotic twin pregnancies and 43 per cent of dizygotic twin pregnancies with Down syndrome would be identified at a 5 per cent false-positive rate. The overall detection rate would be about 53 per cent. When laboratories offer multiple marker screening to women with twin pregnancies, the false-positive rate ought to be similar to that found in singleton pregnancies; the detection rate is, however, likely to be lower for dizygotic twins.
L M Neveux; G E Palomaki; G J Knight; J E Haddow
Related Documents :
12729169 - The first report on the occurrence of twins in a freshwater crayfish, pacifastacus leni...
2085069 - Decrease in twinning rate in a hospital in tokyo during world war ii.
19107619 - Early neonatal morbidity and mortality in growth-discordant twins.
7976109 - Seasonal variation of twin births in washington state.
20184569 - Selected neonatal outcomes in dizygotic twins after ivf versus non-ivf pregnancies.
3276379 - Anthracyclines in the treatment of malignancy in pregnancy.
20015329 - Association study of vascular endothelial growth factor and polymorphisms of its gene w...
15511919 - Elevated serum melatonin levels during human late pregnancy and labour.
25069629 - Outcomes of subsequent pregnancies after conservative treatment for placenta accreta.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Twin Study    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  16     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  1996 Jan 
Date Detail:
Created Date:  1996-11-21     Completed Date:  1996-11-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  29-34     Citation Subset:  IM    
Foundation for Blood Research, Scarborough, ME 04074, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / analysis*
Chorionic Gonadotropin / analysis
Diseases in Twins*
Down Syndrome / diagnosis*
Estriol / analysis
Gestational Age
Maternal Age
Prenatal Diagnosis / methods*
Twins, Dizygotic
Twins, Monozygotic
alpha-Fetoproteins / analysis
Reg. No./Substance:
0/Biological Markers; 0/Chorionic Gonadotropin; 0/alpha-Fetoproteins; 50-27-1/Estriol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Incidence and significance of chromosome mosaicism involving an autosomal structural abnormality dia...
Next Document:  Maternal serum screening for fetal Down syndrome in IVF pregnancies.